UB CAT
The University at Buffalo Center for Advanced Technology in Big Data and Health Sciences (UB CAT) is a project cost-sharing grant program funded by Empire State Development, and designed to drive the growth of life and health science businesses in New York State.
By partnering with a University at Buffalo investigator, New York State companies can access matching funds for collaborative product development or proof of concept research in the health sciences, especially in the areas of drug development, medical devices, diagnostic tools and healthcare IT. Preference will be given to projects that involve or enable Big Data applications.
Health science companies can benefit from: project cost-sharing; outstanding faculty expertise; state-of-the art facilities and equipment; and access to SUNY’s reduced rates on services and supplies.
Eligibility Criteria for Project Funding:
- Proposed projects must align with UB CAT’s focus areas
(big data and health sciences) - Company is registered in NYS and has an office location in NYS
- Company has at least 1 full time employee
- Company has available matching funds for project cost sharing
- Commitment of a University at Buffalo Principal Investigator*
- Scientific, technical, and innovative merit
- Demonstrated need for support of project
- Ability to successfully complete project in one fiscal year
(July-June of the project year) - Potential economic impact for New York State**
- Appropriateness of budget items within UB CAT project guidelines
* All projects are subject to State University of New York intellectual property policies. Click here for special SWIFT for CAT preferred terms.
** Companies that receive CAT funding are required to provide annual economic impact reports for five years. Information on eligible economic impacts and reporting is available upon request.
Current UB CAT Projects:
Current UB CAT projects where faculty and industry have partnered for 2020-2021:
Jun Qu, PhD
Epigenetic Drug Discovery Platform for Methylation Inhibitors
Albert Titus, PhD
Wireless Biosensor System Advancement Project
Dhaval K Shah, PhD
Pharmacological Assessment of AI-Designed Novel Nanobodies for the Treatment of SARS-CoV-2, Variants of SARS-CoV-2, and Future SARS Viruses
Scott Nodzo, MD
Antimicrobial Electrical Stimulation in Swine Knee Model
Mark Ehrensberger, PhD
Live Microbe Imaging of Antimicrobial Electrical Stimulation
Electrical Stimulation Effects on Osseointegration
Immune Modulatory Therapies
Richard Bankert, VMD, PhD
Development and implementation of analytic methods and modeling of big datasets for certain proprietary small molecules in cancer immunotherapy
Neurovascular Diagnostics
John Kolega, PhD
Molecular Biomarkers of Dangerous Intracranial Aneurysms
Praveen Arany, DDS, PhD
Preclinical Optimization and Clinical Testing of Novel Oral Health Products
Pro Al Medico
Brian R. Weil, PhD
T3np Neuroprotection Following Cardiac Arrest
Rheonix
Michael Buck, PhD
Automated DNA Library Prep for NGS
You First Services
Francine Battaglia, PhD
Simulations for the Containment and Control of COVID-19 in Indoor Spaces with the SteriSpace™ Air Sterilization System
Veronomics
Jianxin Wang, PhD
Genomics/Bioinformatics Platforms to Identify Cancer Drugs
APPLY FOR FUNDING
STEP 1:
Companies are invited to submit a Letter of Intent by March 1, 2021.
STEP 2:
Preselected companies are invited to submit a full application (deadline April 15, 2021).